Metabolic derangements are fairly common occurrences in cancer medicine. In many instances, they require deft recognition and prompt institution of emergency therapeutic intervention. These syndromes may result from a primary tumor, metastatic disease, or anti-tumor therapy. This article discusses the management of such patients.
|Original language||English (US)|
|Number of pages||10|
|Journal||Journal of the National Medical Association|
|State||Published - Sep 1991|
ASJC Scopus subject areas